Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 2
1 (100.0%)An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Chromis LLC
- Target Recruit Count
- 330
- Registration Number
- NCT04434248
- Locations
- π·πΊ
Republican Clinical Hospital, Makhachkala, Russian Federation
π·πΊ"K+31" Clinic, Moscow, Russian Federation
π·πΊ"Khaven" Llc, Moscow, Russian Federation
News
No news found